86 filings
Page 2 of 5
8-K
1klwn
31 Dec 18
Prior Approval Supplement for Andexxa® Generation 2 Manufacturing Process
5:21pm
8-K
044tjf imotfu5
11 Dec 18
Other Events
8:15am
8-K
oa6 xm1qw
7 Nov 18
Portola Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
4:11pm
8-K
v2mn92jxz7wd05t
12 Oct 18
Departure of Directors or Certain Officers
4:38pm
8-K
ljed9w5r8gsr56b0y8lg
20 Sep 18
Departure of Directors or Certain Officers
8:44am
8-K
vutl7agz
7 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
92dpz ap9w7ntrou1l8n
9 Aug 18
Portola Pharmaceuticals Reports Second Quarter 2018 Financial Results
8:15am
8-K
k2vez22i8 6y
11 Jun 18
Departure of Directors or Certain Officers
4:30pm
8-K
zwhfoo2q3hi0pbrdf67
4 Jun 18
Portola Pharmaceuticals Announces Retirement of CEO Bill Lis in 2018
12:00am
8-K
56s398 n37
9 May 18
Portola Pharmaceuticals Reports First Quarter 2018 Financial Results
4:12pm
8-K
od9vg
28 Feb 18
Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
lgnjy0dg
6 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
23hqls8x2q
6 Nov 17
Portola Pharmaceuticals Reports Third Quarter 2017 Financial Results
12:00am
8-K
urdaa2dlo
13 Sep 17
Other Events
12:00am
8-K
vf003qht ybpyg
11 Sep 17
Other Events
12:00am
8-K
5t6ix0czwf pu
9 Aug 17
Portola Pharmaceuticals Reports Second Quarter 2017 Financial Results
12:00am
8-K
z5huoj l77acgmjewqj6
19 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
s3s8qhgd6u6fac4r
8 May 17
Portola Pharmaceuticals Reports First Quarter
12:00am
8-K
prahww
8 May 17
Departure of Directors or Certain Officers
12:00am
8-K
s38vai0e3kes th38
28 Feb 17
Portola Pharmaceuticals Reports Fourth Quarter and Year-End
12:00am